Search Ontology:
ChEBI
16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)
- Term ID
- CHEBI:140401
- Synonyms
-
- (4Z,7Z,16S,17R,19Z)-16-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-17-hydroxydocosa-4,7,10,12,14,19-hexaenoate
- 16-cysteinyl,17-hydroxy-4Z,7Z,16S,17R,19Z-docosahexaenoate(1-)
- PCTR3(1-)
- protectin conjugate in tissue regeneration 3(1-)
- Definition
- A docosanoid anion obtained by deprotonation of the two carboxy groups and protonation of the alpha-amino group of 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid; major species at pH 7.3.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Show first 5 Terms
Phenotype
Phenotype resulting from 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)
Phenotype where environments contain 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)
Phenotype modified by environments containing 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)
Phenotype affecting 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(1-)
Human Disease Model